Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Maxine Jaquet Insider Profile
4 Followers
Maxine Jaquet, Chief Executive Officer & Managing Director at Healius Limited, holds 521.16K shares in Healius Limited (Ticker: DE:PGZ). Most recently, Maxine Jaquet Bought €112,078 shares of Healius Limited on Dec 19, 2023 for an estimated value of 134.49K.
Maxine Jaquet has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Chief Executive Officer & Managing Director
Roles that Maxine Jaquet holds in companies
Most Profitable Insider Trade
The most profitable trade made by Maxine Jaquet
Maxine Jaquet's Trading History
List of latest transactions for each holding click on a transaction to see Maxine Jaquet's performance on stock
You May Also Like
Maxine Jaquet insider profile FAQ
What is the percentage of profitable transactions made by Maxine Jaquet?
The percentage of profitable transactions made by Maxine Jaquet is ―.
What is the average return per transaction made by Maxine Jaquet?
The average return per transaction made by Maxine Jaquet is ―.
What stocks does Maxine Jaquet hold?
Maxine Jaquet holds: DE:PGZ stocks.
What was Maxine Jaquet’s latest transaction?
Maxine Jaquet latest transaction was an Informative Buy of €134.49K.
What was Maxine Jaquet's most profitable transaction?
Maxine Jaquet’s most profitable transaction was an Informative Buy of DE:PGZ stock on December 19, 2023. The return on the trade was -2.70%.
What is Maxine Jaquet's role in Healius Limited?
Maxine Jaquet's role in Healius Limited is Chief Executive Officer & Managing Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.